Axsome Therapeutics Inc (AXSM)
87.15
-1.69
(-1.90%)
USD |
NASDAQ |
Nov 04, 16:00
87.16
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Revenue (Quarterly): 87.17M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 87.17M |
| March 31, 2024 | 75.00M |
| December 31, 2023 | 71.53M |
| September 30, 2023 | 57.79M |
| June 30, 2023 | 46.70M |
| Date | Value |
|---|---|
| March 31, 2023 | 94.58M |
| December 31, 2022 | 24.37M |
| September 30, 2022 | 16.85M |
| June 30, 2022 | 8.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.82M
Minimum
Jun 2022
94.58M
Maximum
Mar 2023
53.64M
Average
57.79M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
| Krystal Biotech Inc | 70.28M |
| Pfizer Inc | 17.70B |
| Sarepta Therapeutics Inc | 362.93M |
| Moderna Inc | 221.00M |
| NovaBay Pharmaceuticals Inc | 2.40M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -79.34M |
| Total Expenses (Quarterly) | 163.05M |
| EPS Diluted (Quarterly) | -1.67 |
| Enterprise Value | 4.047B |
| Gross Profit Margin (Quarterly) | 90.76% |
| Profit Margin (Quarterly) | -91.03% |
| Earnings Yield | -7.47% |
| Normalized Earnings Yield | -6.413 |